Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution
Unit-dose, alcohol-free formulation designed to support precise dosing and ease of administration across pediatric, geriatric, dysphagic, and institutional care settings FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#amlodipine—Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S. launch of Sdamlo™ (amlodipine for oral solution), the first and only FDA-approved, … [Read more…]
